The exemption may be short-lived if President Trump makes good on threats to use tariffs as leverage to bring drug production ...

There’s been no shortage of either in recent weeks. Plunging valuations across the biotech sector were thrust into the ...

At least 63 biopharma layoff rounds were conducted in the first quarter of this year, with cell and gene biotechs accounting ...

The Business Journal found 21 Massachusetts life sciences companies announced layoffs impacting at least 1,000 employees ...

British biotech CellCentric is settling into a new office in Boston, part of the company’s expansion into the U.S. as ...

Amid a raft of federal changes cutting funding and capacities at the Food and Drug Administration, investors are soon ...

Explore Q1 2025's biotech stock moves, from CervoMed's 300% surge to Septerna's struggles. Click for my review of the quarter ...

But what it does have is its critical role—albeit underrated—as a biotech hub. Competing with South San Francisco and Boston, ...

Drug developers will now have enhanced abilities to rapidly prototype, test, iterate, and scale up their mRNA therapeutics.

Wacker Biotech announced a strategic collaboration with RNAV8 Bio, a pioneer in mRNA engineering for the development of ...

Technology giant Nvidia announced last Thursday that it will open a quantum computing research center in Boston by the end of ...